Quantcast

Latest Quinolone Stories

2014-10-14 16:26:13

LONDON, Oct. 14, 2014 /PRNewswire/ -- Use this report to:- Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets.- Learn about developments of novel antibiotics to combat multidrug-resistant strains.- Gain information on the market structure, various subsegments of the global antibiotics market. Highlights- The global systemic antibiotics market was valued at $39.6 billion in 2013...

2014-09-25 12:29:22

Drug Pricing Will be Key Factor in Hospital Formulary Uptake of Novel Gram-Negative Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 25, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed infectious diseases (ID) specialists and internists are willing to prescribe Actavis/ AstraZeneca's ceftazidime/avibactam (CAZ-AVI), Cubist's ceftolozane/tazobactam and Tetraphase's eravacycline for the treatment of Gram-negative...

2014-09-22 16:26:20

LONDON, Sept. 22, 2014 /PRNewswire/ -- About AntibioticsAntibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term "antibiotic" is often used synonymously with antibacterial; however, the term "antibiotic" was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell...

2014-09-16 08:30:15

Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc. (SPI), a research-stage biopharmaceutical company developing novel orally active drugs that restore or increase the effectiveness of existing antibiotics, announced today a $1.4 million convertible debt financing. Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc.,...

2014-09-09 23:07:12

Transparency Market Research published a new report "Antibacterial Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Albany, New York (PRWEB) September 09, 2014 An antibacterial drug can be broadly defined as any drug/medicine that inhibits bacterial growth or destroys bacteria in the body. Bacterial infections can often have far reaching health effects on a patient and they show different symptoms based on which...

2014-08-06 08:32:23

LONDON, Aug. 6, 2014 /PRNewswire/ -- LON-ReportbuyerReportbuyer.com has added a new market research report:Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019http://www.reportbuyer.com/pharma_healthcare/therapeutic/antibacterial_drugs_market_by_class_pipeline_analysis_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html Antibacterial Drugs Market (By Class - Aminoglycosides,...

2014-06-17 23:03:04

New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Antibiotics are antimicrobial compounds, used to treat a broad range of various bacterial infections in humans as well as animals and plants. Antibiotics have saved countess lives since their discovery. Antibiotics are effective against certain fungal and bacterial infections and are also used a treatment for...

2014-06-12 08:29:42

DUBLIN, June 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l2jzql/antibacterial) has announced the addition of the "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs...

2014-06-12 08:29:09

FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone in development for impetigo. Ferrer, a privately-help Spanish pharmaceutical company, licensed US rights for Ozenoxacin to Medimetriks earlier this year. The multicenter, randomized, double-blinded, clinical study compares Ozenoxacin 1% cream...

2014-05-23 12:24:30

A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON, May 23, 2014 /PRNewswire-USNewswire/ -- A group of 50 Americans who call themselves "Floxies" because they each took the prescribed antibiotic medication Fluoroquinolone which they allege has had disastrous health consequences, have appealed to members of Congress for help in warning others. In their...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.